Labetalol Hydrochloride Injection, Solution
Product Images NDC 25021-317

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 25021-317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Lab0b 0002 01)

Chemical structure of labetalol hydrochloride, depicting the molecular framework with aromatic rings, hydroxyl groups, an amide group, and the hydrochloride (HCl) component.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Lab0b 0002 02)

Label for labetalol hydrochloride injection, USP, 5 mg/mL, in a 20 mL multi-dose vial. The label specifies a total of 100 mg per 20 mL for intravenous injection only. It includes detailed sterile nonpyrogenic drug content information and manufacturer details for Sagent Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.